Medical Device | Healthcare | Biotechnology | Pharmaceuticals

The growth of neuromodulation market is driven majorly by the rising prevalence of neurological disorders, increasing research into expanding the applications of neuromodulation, and awareness on neurodegenerative disorders. However, the high cost of neuromodulation procedures and equipment, along with the dearth of a trained workforce, is expected to restrain the growth of this market during the forecast period. Neuromodulation Market Dynamics: Impact Analysis 1. Expansion in Emerging Economies 2. Rising Awareness on Neurodegenerative Disorders 3. Research into Expanding the Applications of Neuromodulation 4. Rising Prevalence of Neurological Disorders 5. Rising Incidence of Parkinson’s Disease The global  neuromodulation market  is projected to reach USD 8.8 billion by 2025 from USD 5.8 billion in 2020, at a CAGR of 8.6%. Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global Neuromodulation market? 2. What are the drivers, res

The growth of physiotherapy equipment market is primarily driven by rapidly growing geriatric population and the subsequent increase in the global prevalence of chronic diseases, and growing incidence of sports injuries, degenerative joint disorders, and cerebrovascular disease. Physiotherapy Equipment Market Dynamics: Impact Analysis 1. I ncrease in The Global Prevalence of Chronic Diseases 2. Growing Incidence of Sports Injuries 3. Emerging Markets 4. Technological Advances 5. Wide Range of Applications The physiotherapy equipment market is projected to reach USD 21.1 billion by 2024 from USD 15.1 billion in 2018, at a CAGR of 5.8%. Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global Physiotherapy Equipment market? 2. What are the drivers, restraints, opportunities, and challenges in the Physiotherapy Equipment Industry? 3. What are the opportunities for stakeholders and provide details of the competitive landscape for key

The bioburden testing market is witnessing growth due to factors such as growth in the medical devices, pharmaceutical, and biotechnology industries; rising safety concerns related to food and beverage products; and the increasing number of product recalls due to microbial contamination are expected to drive the growth of this market during the forecast period. Bioburden Testing Market Dynamics: Impact Analysis 1. Geographical Snapshot of the Bioburden Testing Market 2. Growth Opportunities in Emerging Economies 3. Growth in the Medical Devices, Pharmaceutical, and Biotechnology Sector 4. Safety Concerns Related to Food and Beverage Products 5. Increasing Food Imports Into the US The bioburden testing market to grow from USD 1.10 billion by 2023 from USD 0.61 billion in 2018, at a Compound Annual Growth Rate (CAGR) of 12.4% Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global Bioburden Testing market? 2. What are the drivers, r

Growth in the risk based monitoring software market can primarily be attributed to factors such as the cost and time efficiency of RBM solutions, rising number of clinical trials, and increasing government funding and grants to support clinical trials. However, the high implementation cost of RBM solutions is expected to restrain the growth of this market during the forecast period. RBM Software Market Dynamics: Impact Analysis 1. Increased outsourcing of clinical trial processes to CROs 2. Cost and time efficiency of RBM solutions 3. Increasing government funding and grants to support clinical trials 4. Increased pharmaceutical R&D spending 5. Initiatives to boost digital health to propel market growth The risk-based monitoring (RBM) software market is expected to reach USD 511 million by 2025 from USD 273 million in 2020, at a CAGR of 13.3% Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102112429 Software Component: The software

The growth of adhesion market is driven by the growth in the geriatric population and corresponding age-related chronic diseases, epidemiological shift from infectious to chronic diseases, growing volume of surgical procedures and sports-related injuries, and increasing awareness about the medical complications occurred due to post-surgical adhesion formation. Adhesion Barrier Market Dynamics: Impact Analysis 1. Increasing Awareness About the Medical Implications of Adhesions 2. Increase in the Volume of Surgeries and Sports-Related Injuries 3. Rising Focus on Gel-Form Adhesion Barriers for Surgeries The adhesion barrier market is valued at 536.6 Million in 2017 and is expected to grow at a CAGR of 7.2% during the forecast period (2018 to 2023), to reach to USD 806.4 Million by 2023. Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global Adhesion Barrier market? 2. What are the drivers, restraints, opportunities, and challenges in

Increase in obese population and rising incidence of sports injuries are the major factors driving the demand of cartilage regeneration. On the other hand, high cost of therapy and unfavorable reimbursement scenario are the major factors restraining the growth of cartilage regeneration market. What the market looks like? The cartilage regeneration market is projected to reach USD 779.8 Million by 2021 from USD 414.6 Million in 2016, growing at a CAGR of 13.5%. Treatment Modalities Segment: Based on treatment modalities, the market is segmented into cell based approaches and non-cell based approaches. Cell based approaches are further segmented into chondrocyte transplantation, growth factor technology, and stem cells. Non-cell based approaches are segmented into tissue scaffolds and cell-free composites. The cell based approaches segment is expected to account for the largest market share. This treatment modality segment is also expected to be the fastest growing segment in

The major factors driving the growth of diagnostic imaging services market include the rapidly growing geriatric population and the subsequent increase in the prevalence of associated diseases and growing awareness about early disease detection and the widening scope of clinical applications. On the other hand, factors such as the high cost of diagnostic imaging systems and the low reimbursement structure for outpatient imaging facilities are likely to restrain the growth of the market to a certain extent in the coming years. The diagnostic imaging services market is projected to reach USD 693.4 billion by 2024 from USD 539.7 billion in 2019, at a CAGR of 5.1% from 2019 to 2024. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=17157849 X-Ray Segment: The x-ray segment accounted for the largest share of the market. The key factors driving the growth of this market include the rising geriatric population, lower cost of X-rays as compared to oth

The growth of adhesion barrier market is driven by the growth in the geriatric population and corresponding age-related chronic diseases, epidemiological shift from infectious to chronic diseases, growing volume of surgical procedures and sports-related injuries, and increasing awareness about the medical complications occurred due to post-surgical adhesion formation. What the adhesion barrier market looks like? The global adhesion barrier market is projected to reach USD 806.4 Million by 2023 from USD 570.7 Million in 2018, at a CAGR of 7.2%. Increasing awareness about the medical implications of adhesions: Post-surgical adhesions are a common complication in various types of surgeries. The knowledge and understanding of adhesions and adhesion-related complications have increased in the last decade. Various surgical associations, as well as hospitals, are focusing on increasing the awareness about post-surgical adhesion formation and the available anti-adhesive products to c

The key factors driving the growth of PDX Models Market include the growing demand for personalized medicine, continuous support for cancer research from the public as well as private sectors, and growth in the number of R&D activities in the pharmaceutical industry. The growing use of humanized PDX models is posing a lucrative opportunity in this market. What the market looks like? The PDX models market is expected to reach USD 167.6 Million by 2022 from an estimated USD 77.4 Million in 2017, at a CAGR of 16.7%. Objectives of Study: 1. To define, describe, and measure the global Patient Derived Xenograft (PDX) models market by model type, tumor type, application, end user, and region . 2. To provide detailed information regarding the major factors, such as drivers, restraints, growth opportunities, and challenges influencing the growth of the market . 3. To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contribution

The autoimmune disease diagnosis market is experiencing significant growth due to the high incidence of autoimmune diseases, increasing awareness about autoimmune diseases, and the growth in research on autoimmune diseases. What the market looks like? The global autoimmune disease diagnosis market size is expected to grow from USD 6.3 billion by 2025 from USD 4.1 billion in 2020, at a CAGR of 8.9%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174826519 Consumables & assay kits segment to dominate the autoimmune disease diagnosis market: The consumables & assay kits segment is expected to grow at the highest growth rate during the forecast period. This is attributed primarily to the rising incidence of autoimmune disease and the increasing number of product launches/approvals. Routine laboratory tests segment: Based on the test type, the autoimmune disease diagnosis industry is segmented into routine laboratory tests, inflammat

The growth of 3d cell culture market is driven mainly by the increasing focus on developing alternatives to animal testing, growing focus on personalized medicine, increasing incidence of chronic diseases, and the availability of funding for research. On the other hand, the lack of infrastructure for 3D cell-based research and the high cost of cell biology research are expected to restrain the growth of this market during the forecast period. What the market looks like? The global 3D cell culture market size is projected to reach USD 1,846 million in 2024 from USD 892 million in 2019, at a CAGR of 15.7%. Cancer and Stem Cell Research Application: The cancer & stem cell research segment accounted for the largest share of 3d cell culture market in 2018 and is expected to register the highest CAGR during the forecast period. The increasing prevalence of cancer and significant funding for cancer research are major factors driving the growth of this application segment. Down

In the current global scenario-where the focus on biologics and biosimilars has risen-it is expected that the benefits of advanced healthcare analytical testing services will ensure their greater adoption. The increasing demand for specialized testing services, the number of clinical trials, and the acceptance of the QbD approach in pharmaceutical research and manufacturing are other factors driving the growth of healthcare analytical testing services market. Pharmaceuticals and Biotechnology Sector to Dominate The Industry: Pharmaceutical & biopharmaceutical companies hold the largest share in the market. The largest share of this segment in the market can be attributed to the tremendous amount of analytical testing required to support a product from discovery, development, and clinical trials, through manufacturing and marketing. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=108923833 The batch-release testing segment is projected to

Oligonucleotide synthesis market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques. What the Market Looks Like? The global oligonucleotide synthesis market is projected to reach USD 8.2 billion by 2024 from USD 4.3 billion in 2019, at a CAGR of 13.7%. Therapeutic Application: The therapeutic applications segment, which is further segmented into RNAi oligonucleotide-based therapies, DNA & antisense oligonucleotide-based therapies, and CpG oligonucleotide-based therapies, is estimated to witness the highest growth during the forecast period. This can primarily be attributed to the investments made by companies to explore the therapeutic applications of oligos. Also, from 2016 to 2018, more than five oligonucleotide-based therapies were approved by the FDA. In 2018, these oligonucleotide-based drugs generated a revenue of ~USD 2 billion. Apa

The key factors driving the growth of PDX Models Market include the growing demand for personalized medicine, continuous support for cancer research from the public as well as private sectors, and growth in the number of R&D activities in the pharmaceutical industry. The growing use of humanized PDX models is posing a lucrative opportunity in this market. What the market looks like? The PDX models market is expected to reach USD 167.6 Million by 2022 from an estimated USD 77.4 Million in 2017, at a CAGR of 16.7%. Tumor Type: The gastrointestinal tumors segment is expected to account for the largest share of the global PDX models market. The respiratory tumors segment, on the other hand, is expected to be the fastest-growing segment during the forecast period. Growth in this segment is mainly driven by the increasing focus of market players on generating lung cancer PDX models, which could lead to a breakthrough in lung cancer treatment as lung cancer is the leading cause

The market for healthcare information technology is driven primarily by the rising incidence of COVID-19, government mandates, support and initiatives for HCIT solutions, the increasing use of big data in healthcare, high returns on investment for HCIT solutions, and the need to curtail escalating healthcare costs. However, high costs of solutions, implementation, and infrastructure, and concerns regarding data security are likely to challenge the growth of this market. What the market looks like? The global healthcare information technologies market size is projected to reach USD 270.3 billion by 2021 from USD 227.5 billion in 2020, at a CAGR of 23.6% The telehealth segment is expected to grow at the highest CAGR during the forecast period. The use of telehealth solutions facilitates remote doctor-patient consultations (telemedicine) and vital sign monitoring. These solutions enable medical practitioners to evaluate & diagnose patients, ePrescribe medicines & treatment